Icon (ICLR) 21.72 -0.24

Icon Plc
(ICLR) 21.72 -0.24

Last Trade:	21.70	Day Range:	21.37 - 21.86
Trade Time:	04:05PM	52wk Range:	15.03 - 25.93
Prev. Close:	21.94	Market Cap:	1.3B
Open:	21.68	Div Yield:	0
Volume:	148889	PE:
EPS:	0.00

The Latest On ICLR

UPDATE: Jefferies Raises PT to $24 on ICON; Solid Qtr 4/25/12 9:49am

ICON Acquires PriceSpective 2/28/12 7:35am

UPDATE: Jefferies Raises Target to $18.50 on ICON 2/17/12 12:12pm

UPDATE: Sterne Agee Upgrades ICON 2/15/12 10:07am

Sterne Agee Upgrades Icon from Underperform to Neutral, Raises PT to $21 2/15/12 8:14am

ICON Selected by Shire as Global Strategic Partner for Clinical Research and Central Laboratory Services 1/9/12 8:21am

Deutsche Bank Downgrades ICON to Hold 1/3/12 2:06pm

Market Roundup 12/27/11 2:47pm

ICON Announces Dr. Anthony Murphy To Retire From Board of Directors 12/27/11 7:46am

ICON Acquires BeijingWits Medical Consulting Ltd 12/12/11 7:50am

ICON Acquires BeijingWits Medical Consulting 12/12/11 7:48am

Tasly Pharmaceuticals Selects ICON as it Seeks First FDA Approval of a Traditional Chinese Medicine 11/22/11 6:23pm

UPDATE: Jefferies Raises PT to $24 on ICON; Solid Qtr 4/25/12

ICON Acquires PriceSpective 2/28/12

UPDATE: Jefferies Raises Target to $18.50 on ICON 2/17/12

UPDATE: Sterne Agee Upgrades ICON 2/15/12

Sterne Agee Upgrades Icon from Underperform to Neutral, Raises PT to $21 2/15/12

ICON Selected by Shire as Global Strategic Partner for Clinical Research and Central Laboratory Services 1/9/12

Deutsche Bank Downgrades ICON to Hold 1/3/12

Market Roundup 12/27/11

ICON Announces Dr. Anthony Murphy To Retire From Board of Directors 12/27/11

ICON Acquires BeijingWits Medical Consulting Ltd 12/12/11

ICON Acquires BeijingWits Medical Consulting 12/12/11

Tasly Pharmaceuticals Selects ICON as it Seeks First FDA Approval of a Traditional Chinese Medicine 11/22/11

Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest EPS Estimates (ICLR, PRXL, BRLI, MTOX) 4/20/11

Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Revenue (PRXL, ICLR, AIQ, BRLI) 3/15/11

Mad Money Lightning Round OT: Cramer Thinks That TRGL Should Be Bought (ICLR, ERTS, TRGL) 2/8/11

Mad Money Lightning Round: Cramer Likes Honeywell (HON, JAZZ, ICLR, ANDE, DE, TSCO, STD, FCS, BIDU, GOOG, NAT) 11/9/10

Three Stocks Seeing Record Volume (FNF, PLCE, ICLR) 10/21/10

Benzinga's Volume Movers (ICLR, TZOO, ALXN, MAT) 10/21/10

Deutsche Bank: ICLR And CVD Continue To Be Best Secular Growth Stories In CRO Space 7/13/10

Benzinga’s Volume Movers (VLTR, AMLN, PRXL, ICLR, ZION) 1/26/10

UPDATE: Jefferies Raises PT to $24 on ICON; Solid Qtr 4/25/12

UPDATE: Jefferies Raises Target to $18.50 on ICON 2/17/12

UPDATE: Sterne Agee Upgrades ICON 2/15/12

Sterne Agee Upgrades Icon from Underperform to Neutral, Raises PT to $21 2/15/12

Deutsche Bank Downgrades ICON to Hold 1/3/12

UPDATE: JP Morgan Downgrades ICLR To Neutral, Lowers PT to $18 10/10/11

JP Morgan Downgrades ICON Plc to Neutral, PT Lowered to $18 10/10/11

Jefferies Downgrades ICON plc to Hold from Buy and Lowers PT from $28 to $21.50 7/21/11

Jefferies Downgrades ICLR, PRXL 7/21/11

Deutsche Bank Maintains Buy Rating On CVD, ICLR 4/14/11

Deutsche Bank Reiterates Buy Rating On CVD And ICLR 4/5/11

Jefferies Prime Time AM Tickers 1/25/11

Trade ICLR
NOW!

Partner Headlines

VirtualScopics Reaches the Black in 4Q - Analyst Blog 2/24/12

Up/Downgrades ( BBVA, BAC, ZNGA, DELL, TAL, CPA, ICLR, DFT, XCO, PRXL ) 2/15/12

Taking Advantage of Europe's Pain 2/6/12

VirtualScopics, PPD Expand Ties - Analyst Blog 1/30/12

10 Top Morningstar M&A Stock Picks 1/20/12

The Long-Term Play In Lab Work (BBH, CRL, ICLR, PRXL, WX) 1/16/12

Bearish MACD for ICLR - Tale of the Tape 12/7/11

PPD Goes Private (PPDI, CVD, PRXL, CRL, ICLR, ERT, PFE, MRK) 10/6/11

Zacks #5 Rank Additions for Tuesday - Tale of the Tape 3/1/11

Parexcel: Great Growth but a Tough Business

Parexel: Great Growth but a Tough Business

Press Releases

ICON reports a 10% increase in first quarter 2012 revenue to $252m, up 10% year on year, EPS of 15 cents, net new business awards of $385 million and a B:B of 1.5. (NASDAQ:ICLR) (ISIN:IE0005711209) 4/24/12 Business Wire

ICON Acquires PriceSpective 2/28/12 Business Wire

ICON reports fourth quarter 2011 revenue of $243m, up 5% year on year, and EPS of $0.07. Backlog increases 19%. (NASDAQ:ICLR) (ISIN:IE0005711209) 2/16/12 Business Wire

ICON Announces Dr. Anthony Murphy To Retire From Board of Directors 12/27/11 Business Wire

Get the latest ICLR stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Icon Plc stock price.

Icon Plc by YCharts

Icon (ICLR) 21.72 -0.24

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On ICLR

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social